Evogene (Israel) Odds of Future Stock Price Finishing Over 2854.0
| EVGN Stock | ILA 530.00 10.60 2.04% |
Evogene |
Evogene Target Price Odds to finish over 2854.0
The tendency of Evogene Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 2,854 or more in 90 days |
| 530.00 | 90 days | 2,854 | near 1 |
Based on a normal probability distribution, the odds of Evogene to move over 2,854 or more in 90 days from now is near 1 (This Evogene probability density function shows the probability of Evogene Stock to fall within a particular range of prices over 90 days) . Probability of Evogene price to stay between its current price of 530.00 and 2,854 at the end of the 90-day period is about 92.33 .
Assuming the 90 days trading horizon Evogene has a beta of -0.53 suggesting as returns on the benchmark increase, returns on holding Evogene are expected to decrease at a much lower rate. During a bear market, however, Evogene is likely to outperform the market. Additionally Evogene has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Evogene Price Density |
| Price |
Predictive Modules for Evogene
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evogene. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Evogene Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Evogene is not an exception. The market had few large corrections towards the Evogene's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Evogene, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Evogene within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.6 | |
β | Beta against Dow Jones | -0.53 | |
σ | Overall volatility | 329.64 | |
Ir | Information ratio | -0.4 |
Evogene Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Evogene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Evogene can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Evogene generated a negative expected return over the last 90 days | |
| Evogene has high historical volatility and very poor performance | |
| The company reported the revenue of 930 K. Net Loss for the year was (27.79 M) with profit before overhead, payroll, taxes, and interest of 163 K. | |
| Evogene has accumulated about 65.36 M in cash with (24.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.61. |
Evogene Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Evogene Stock often depends not only on the future outlook of the current and potential Evogene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evogene's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.2 M |
Evogene Technical Analysis
Evogene's future price can be derived by breaking down and analyzing its technical indicators over time. Evogene Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Evogene. In general, you should focus on analyzing Evogene Stock price patterns and their correlations with different microeconomic environments and drivers.
Evogene Predictive Forecast Models
Evogene's time-series forecasting models is one of many Evogene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Evogene's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Evogene
Checking the ongoing alerts about Evogene for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Evogene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Evogene generated a negative expected return over the last 90 days | |
| Evogene has high historical volatility and very poor performance | |
| The company reported the revenue of 930 K. Net Loss for the year was (27.79 M) with profit before overhead, payroll, taxes, and interest of 163 K. | |
| Evogene has accumulated about 65.36 M in cash with (24.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.61. |
Additional Information and Resources on Investing in Evogene Stock
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:Check out Evogene Backtesting, Evogene Valuation, Evogene Correlation, Evogene Hype Analysis, Evogene Volatility, Evogene History as well as Evogene Performance. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.